Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Bushnell

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
American Journal of Clinical Oncology|May 4, 2022
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE TherapyCharito Love, Neil B Desai, Tony Abraham, et al.
Clinical Nuclear Medicine|May 4, 2022
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE TherapyCharito Love, Neil B Desai, Tony Abraham, et al.
Journal of the National Cancer Institute|May 31, 2023
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meetingSimron Singh, Thomas A Hope, Emily B Bergsland, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
American Journal of Clinical Oncology|May 4, 2022
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE TherapyCharito Love, Neil B Desai, Tony Abraham, et al.
Clinical Nuclear Medicine|May 4, 2022
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE TherapyCharito Love, Neil B Desai, Tony Abraham, et al.
Journal of the National Cancer Institute|May 31, 2023
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meetingSimron Singh, Thomas A Hope, Emily B Bergsland, et al.
Pageof 3